Jeff Jin, PhD, on Hepatitis C Virus Rates Among Men Who Have Sex With Men

08/25/2021

Podcasts360 · Jeff Jin, PhD, on Hepatitis C Rates Among Men Who Have Sex With Men

In this podcast, Jeff Jin, PhD, discusses his team's recent study, which examined the prevalence of hepatitis C virus infection among men who have sex with men.

Additional Resource:

Jin F, Dore GJ, Matthews G, et al. Prevalence and incidence of hepatitis C virus infection in men who have sex with men: a systematic review and meta-analysis. Lancet Gastroenterol Hepatol. 2021;6(1):39-56. https://doi.org/10.1016/s2468-1253(20)30303-4

Jeff Jin, PhD, is a senior lecturer and infectious disease and cancer epidemiologist at the Kirby Institute at the University of New South Wales in Sydney, Australia.

Current Consultant Issue

Previous Issues

Early View

Research Summaries

Research Summary

Semaglutide Reduces Abdominal VAT in Patients With HIV-Related Lipohypertrophy

12/11/2024

Miranda Manier, BA

A clinical trial suggests semaglutide significantly reduces abdominal fat in HIV-associated lipohypertrophy, but the potential for adverse events warrant further investigation.

12/11/2024

Conference Coverage

Mosunetuzumab as a Treatment Option for Patients With Relapsed or Refractory Mantle Cell Lymphoma

12/10/2024

Anthony Calabro, MA

Researchers report on the first safety and efficacy of mosunetuzumab, a CD20xCD3 T-cell engaging bispecific antibody, for patients with relapsed/refractory Mantle cell lymphoma. This study was presented at...

12/10/2024

Conference Coverage

Conference Coverage

How Effective Is the Ibrutinib-Venetoclax-Obinutuzumab Triplet in Mantle Cell Lymphoma?

12/10/2024

Miranda Manier, BA

The OASIS trial evaluates the efficacy of ibrutinib, venetoclax, and obinutuzumab in newly diagnosed mantle cell lymphoma, reporting a 5-year progression-free survival (PFS) rate of 80% and overall survival...

12/10/2024

Conference Coverage

Patients with Mantle Cell Lymphoma Treated With cBTKi With and Without Cytotoxic Chemotherapy

12/09/2024

Anthony Calabro, MA

Researchers analyzed data from a nationwide cohort to evaluate the effectiveness of covalent Bruton tyrosine kinase inhibitors, used either as monotherapy or in combination with anti-CD20 monoclonal...

12/09/2024

Research Summary

Illustration of an x-ray of person's body, with the kidneys highlighted.

Research Summary

Study: Obinutuzumab Improves Kidney Outcomes in Lupus Nephritis

12/09/2024

Miranda Manier, BA

Post hoc analyses of the phase 2 NOBILITY trial reveal that adding obinutuzumab to standard lupus nephritis therapy enhances kidney preservation and reduces glucocorticoid reliance.

12/09/2024

Trending Articles

Pop Quiz

What Do You Know About Endometrial Cancer?

11/11/2024

The risk for endometrial cancer increases as women get older. Which of the following is NOT a risk factor for endometrial cancer?A. Overweight and obesityB. Family historyC. Having multiple childrenD....

11/11/2024

Roundtable

Roundtable

Initiating Resmetirom for Patients With MASH: Recommendations on Patient Selection, Treatment Response, and Patient Monitoring

12/12/2024

In this video, Naim Alkhouri MD, FAASLD, moderates a roundtable discussion with Amreen M. Dinani, MD, FRCPC, and Mazen Noureddin, MD, MHSc, on the practical clinical applications associated with...

12/12/2024

ROUNDTABLE

ROUNDTABLE

Key Updates on the Treatment and Management of MASH

10/08/2024

In this video, James Matera, DO, moderates a roundtable discussion with Colin Browm, MD, Kunal Gupta MD, and Lisa Jones, MA, RDN, LDN, FAND, on recent developments regarding the treatment and management...

10/08/2024